Showing results (1-10 of 112) with videos related to
Sort By:
Pageof 12
Current Hypertension Reports|April 29, 2010
Angiotensin-converting enzyme 2: central regulator for cardiovascular functionHuijing Xia, Eric LazartiguesJournal of Neurochemistry|November 19, 2008
Angiotensin-converting enzyme 2 in the brain: properties and future directionsHuijing Xia, Eric LazartiguesHypertension (Dallas, Tex. : 1979)|December 10, 2014
Brain-targeted angiotensin-converting enzyme 2 overexpression attenuates neurogenic hypertension by inhibiting cyclooxygenase-mediated inflammationSrinivas Sriramula, Huijing Xia, Ping Xu, et al.Methods in Molecular Biology (Clifton, N.J.)|January 25, 2017
Determining the Enzymatic Activity of Angiotensin-Converting Enzyme 2 (ACE2) in Brain Tissue and Cerebrospinal Fluid Using a Quenched Fluorescent SubstrateSrinivas Sriramula, Kim Brint Pedersen, Huijing Xia, et al.Circulation Research|September 10, 2013
Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertensionHuijing Xia, Srinivas Sriramula, Kavaljit H Chhabra, et al.Experimental Physiology|November 20, 2009
Angiotensin-converting enzyme 2: a new target for neurogenic hypertensionYumei Feng, Huijing Xia, Robson A Santos, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 2, 2011
Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assaysKim Brint Pedersen, Srinivas Sriramula, Kavaljit H Chhabra, et al.Hypertension (Dallas, Tex. : 1979)|September 17, 2014
Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanismMatthew R Deshotels, Huijing Xia, Srinivas Sriramula, et al.Hypertension (Dallas, Tex. : 1979)|January 7, 2009
Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive miceHuijing Xia, Yumei Feng, Teresa D Obr, et al.Diabetes|July 28, 2010
Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic miceSharell M Bindom, Chetan P Hans, Huijing Xia, et al.Pageof 12